AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Modelling and simulation in clinical drug development
Authors: Rooney, KF Snoeck, E Watson, PH
Citation: Kf. Rooney et al., Modelling and simulation in clinical drug development, DRUG DISC T, 6(15), 2001, pp. 802-806
Genetic model of multi-step breast carcinogenesis involving the epitheliumand stroma: clues to tumour-microenvironment interactions
Authors: Kurose, K Hoshaw-Woodard, S Adeyinka, A Lemeshow, S Watson, PH Eng, C
Citation: K. Kurose et al., Genetic model of multi-step breast carcinogenesis involving the epitheliumand stroma: clues to tumour-microenvironment interactions, HUM MOL GEN, 10(18), 2001, pp. 1907-1913
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
Authors: Chia, SK Wykoff, CC Watson, PH Han, C Leek, RD Pastorek, J Gatter, KC Ratcliffe, P Harris, AL
Citation: Sk. Chia et al., Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma, J CL ONCOL, 19(16), 2001, pp. 3660-3668
Expression of PTHrP and PTHR (PTH/PTHrP-r) mRNAs and polypeptides in bovine ovary and stimulation of bovine blastocyst development in vitro followingPTHrP treatment during oocyte maturation
Authors: Watson, PH Westhusin, ME Watson, AJ
Citation: Ph. Watson et al., Expression of PTHrP and PTHR (PTH/PTHrP-r) mRNAs and polypeptides in bovine ovary and stimulation of bovine blastocyst development in vitro followingPTHrP treatment during oocyte maturation, ANAT EMBRYO, 203(3), 2001, pp. 175-184
Extracellular calcium-sensing receptor is expressed in rat hepatocytes - Coupling to intracellular calcium mobilization and stimulation of bile flow
Authors: Canaff, L Petit, JL Kisiel, M Watson, PH Gascon-Barre, M Hendy, GN
Citation: L. Canaff et al., Extracellular calcium-sensing receptor is expressed in rat hepatocytes - Coupling to intracellular calcium mobilization and stimulation of bile flow, J BIOL CHEM, 276(6), 2001, pp. 4070-4079
Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and Nm23
Authors: Tseng, YH Vicent, D Zhu, JH Niu, YL Adeyinka, A Moyers, JS Watson, PH Kahn, CR
Citation: Yh. Tseng et al., Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and Nm23, CANCER RES, 61(5), 2001, pp. 2071-2079
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density
Authors: Beasley, NJP Wykoff, CC Watson, PH Leek, R Turley, H Gatter, K Pastorek, J Cox, GJ Ratcliffe, P Harris, AL
Citation: Njp. Beasley et al., Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density, CANCER RES, 61(13), 2001, pp. 5262-5267
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast
Authors: Wykoff, CC Beasley, N Watson, PH Campo, L Chia, SK English, R Pastorek, J Sly, WS Ratcliffe, P Harris, AL
Citation: Cc. Wykoff et al., Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast, AM J PATH, 158(3), 2001, pp. 1011-1019
Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis
Authors: Hodsman, AB Kisiel, M Adachi, JD Fraher, LJ Watson, PH
Citation: Ab. Hodsman et al., Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis, BONE, 27(2), 2000, pp. 311-318
Nuclear localization of the type 1 parathyroid hormone parathyroid hormone-related peptide receptor in MC3T3-E1 cells: Association with serum-inducedcell proliferation
Authors: Watson, PH Fraher, LJ Natale, BV Kisiel, M Hendy, GN Hodsman, AB
Citation: Ph. Watson et al., Nuclear localization of the type 1 parathyroid hormone parathyroid hormone-related peptide receptor in MC3T3-E1 cells: Association with serum-inducedcell proliferation, BONE, 26(3), 2000, pp. 221-225
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues
Authors: Leygue, E Dotzlaw, H Watson, PH Murphy, LC
Citation: E. Leygue et al., Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues, BREAST CA R, 2(1), 2000, pp. 64-72
Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues
Authors: Watson, PH Fraher, LJ Hendy, GN Chung, UI Kisiel, M Natale, BV Hodsman, AB
Citation: Ph. Watson et al., Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues, J BONE MIN, 15(6), 2000, pp. 1033-1044
Rapid small-animal dual-energy X-ray absorptiometry using digital radiography
Authors: Holdsworth, DW Thornton, MM Drost, D Watson, PH Fraher, LJ Hodsman, AB
Citation: Dw. Holdsworth et al., Rapid small-animal dual-energy X-ray absorptiometry using digital radiography, J BONE MIN, 15(12), 2000, pp. 2451-2457
The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu(27)]cyclo(Glu(22)-Lys(26))hPTH-(1-31)NH2, and hPTH-(1-30)NH2
Authors: Whitfield, JF Morley, P Fraher, L Hodsman, AB Holdsworth, DW Watson, PH Willick, GE Barbier, JR Gulam, M Isaacs, RJ MacLean, S Ross, V
Citation: Jf. Whitfield et al., The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu(27)]cyclo(Glu(22)-Lys(26))hPTH-(1-31)NH2, and hPTH-(1-30)NH2, CALCIF TIS, 66(4), 2000, pp. 307-312
Lumican and decorin are differentially expressed in human breast carcinoma
Authors: Leygue, E Snell, L Dotzlaw, H Troup, S Hiller-Hitchcock, T Murphy, LC Roughley, PJ Watson, PH
Citation: E. Leygue et al., Lumican and decorin are differentially expressed in human breast carcinoma, J PATHOLOGY, 192(3), 2000, pp. 313-320
Hypoxia-inducible expression of tumor-associated carbonic anhydrases
Authors: Wykoff, CC Beasley, NJP Watson, PH Turner, KJ Pastorek, J Sibtain, A Wilson, GD Turley, H Talks, KL Maxwell, PH Pugh, CW Ratcliffe, PJ Harris, AL
Citation: Cc. Wykoff et al., Hypoxia-inducible expression of tumor-associated carbonic anhydrases, CANCER RES, 60(24), 2000, pp. 7075-7083
Altered expression of estrogen receptor coregulators during human breast tumorigenesis
Authors: Murphy, LC Simon, SLR Parkes, A Leygue, E Dotzlaw, H Snell, L Troup, S Adeyinka, A Watson, PH
Citation: Lc. Murphy et al., Altered expression of estrogen receptor coregulators during human breast tumorigenesis, CANCER RES, 60(22), 2000, pp. 6266-6271
Expression of a repressor of estrogen receptor activity in human breast tumors: Relationship to some known prognostic markers
Authors: Simon, SLR Parkes, A Leygue, E Dotzlaw, H Snell, L Troup, S Adeyinka, A Watson, PH Murphy, LC
Citation: Slr. Simon et al., Expression of a repressor of estrogen receptor activity in human breast tumors: Relationship to some known prognostic markers, CANCER RES, 60(11), 2000, pp. 2796-2799
Multiple facets of estrogen receptor in human breast cancer
Authors: Murphy, LC Leygue, E Dotzlaw, H Coutts, A Lu, B Huang, AH Watson, PH
Citation: Lc. Murphy et al., Multiple facets of estrogen receptor in human breast cancer, CONT ENDOC, 2000, pp. 17-34
Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat
Authors: Hodsman, AB Watson, PH Drost, D Holdsworth, D Thornton, M Hock, J Bryant, H Fraher, LJ
Citation: Ab. Hodsman et al., Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat, BONE, 24(5), 1999, pp. 451-455
Enhanced osteoblast development after continuous infusion of hPTH(1-84) inthe rat
Authors: Watson, PH Fraher, LJ Kisiel, M DeSousa, D Hendy, G Hodsman, AB
Citation: Ph. Watson et al., Enhanced osteoblast development after continuous infusion of hPTH(1-84) inthe rat, BONE, 24(2), 1999, pp. 89-94
The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats
Authors: Hodsman, AB Drost, D Fraher, LJ Holdsworth, D Thornton, M Hock, J Bryant, H Watson, PH
Citation: Ab. Hodsman et al., The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats, J BONE MIN, 14(5), 1999, pp. 675-679
Classification of breast tumors by grade and steroid receptor status usingpattern recognition analysis of infrared spectra
Authors: Jackson, M Mansfield, JR Dolenko, B Somorjai, RL Mantsch, HH Watson, PH
Citation: M. Jackson et al., Classification of breast tumors by grade and steroid receptor status usingpattern recognition analysis of infrared spectra, CANCER DET, 23(3), 1999, pp. 245-253
Estrogen receptor-alpha mRNA variants in murine and human tissues
Authors: Lu, B Dotzlaw, H Leygue, E Murphy, LJ Watson, PH Murphy, LC
Citation: B. Lu et al., Estrogen receptor-alpha mRNA variants in murine and human tissues, MOL C ENDOC, 158(1-2), 1999, pp. 153-161
Influence of estrogen receptor variants on the determination of ER status in human breast cancer
Authors: Huang, AH Leygue, E Dotzlaw, H Murphy, LC Watson, PH
Citation: Ah. Huang et al., Influence of estrogen receptor variants on the determination of ER status in human breast cancer, BREAST CANC, 58(3), 1999, pp. 219-225
Risultati: 1-25 | 26-34